Platelet microvesicles in health and disease

Platelets

Volumn 28, Issue 3, 2017, Pages 214-221

  Melki, Imene ^a   Tessandier, Nicolas ^a   Zufferey, Anne ^a   Boilard, Eric ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Disease; health; microvesicles; platelet microparticles

Indexed keywords

BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CARDIOVASCULAR DISEASE; HEMOSTASIS; HUMAN; MALIGNANT NEOPLASM; MEMBRANE MICROPARTICLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOSIS; TUMOR VASCULARIZATION; APOPTOSIS; BLOOD; BLOOD CLOTTING; CHEMISTRY; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; RHEUMATOID ARTHRITIS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION;

BIOLOGICAL MARKER;

APOPTOSIS; ARTHRITIS, RHEUMATOID; BIOMARKERS; BLOOD COAGULATION; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CELL-DERIVED MICROPARTICLES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PLATELET ACTIVATION; PLATELET ADHESIVENESS; THROMBOSIS;

EID: 85018743560     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2016.1265924     Document Type: Review

References (104)

1. Wolf P., The nature and significance of platelet products in human plasma. Br J Haematol 1967;13:269–288.
2. Webber AJ, Johnson SA., Platelet participation in blood coagulation aspects of hemostasis. Am J Pathol 1970;60:19–42.
3. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ., Activated platelets release two types of membrane vesicles:microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999;94:3791–3799.
4. Aatonen MT, Öhman T, Nyman TA, Laitinen S, Grönholm M, Siljander PR-M., Isolation and characterization of platelet-derived extracellular vesicles. J Extracell Vesicles 2014;3.
5. Hargett LA, Bauer NN., On the origin of microparticles:From “platelet dust” to mediators of intercellular communication. Pulm Circ 2013;3:329–340.
6. Zwaal RF, Bevers EM, Comfurius P., Rosing J, Tilly RH, Verhallen PF. Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Mol Cell Biochem 1989;91:23–31.
7. Bevers EM, Comfurius P, Zwaal RFA., Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta BBA Biomembr 1983;736:57–66.
8. Comfurius P, Senden JM, Tilly RH, Schroit AJ, Bevers EM, Zwaal RF., Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1990;1026:153–160.
9. Fujii T, Sakata A, Nishimura S, Eto K, Nagata S., TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets. Proc Natl Acad Sci 2015;112:12800–12805.
10. Suzuki J, Umeda M, Sims PJ, Nagata S., Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010;468:834–838.
11. Gupta N, Li W, Willard B, Silverstein RL McIntyre TM. Proteasome proteolysis supports stimulated platelet function and thrombosis. Arterioscler Thromb Vasc Biol 2014;34:160–168.
12. Tersteeg C, Heijnen HF, Eckly A, Pasterkamp G, Urbanus RT, Maas C, Hoefer IE, Nieuwland R, Farndale RW, Gachet C, et al. FLow-Induced PRotrusions (FLIPRs) a platelet-derived platform for the retrieval of microparticles by monocytes and neutrophils. Circ Res 2014;114:780–791.
13. Dean WL, Lee MJ, Cummins TD, Schultz DJ, Powell DW., Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost 2009;102:711–718.
14. Shai E, Rosa I, Parguiña AF, Motahedeh S, Varon D, García Á., Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics 2012;76:287–296.
15. Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF., The platelet microparticle proteome. J Proteome Res 2005;4:1516–1521.
16. Marcoux G, Duchez A-C, Cloutier N, Provost P, Nigrovic PA, Boilard E., Revealing the diversity of extracellular vesicles using high-dimensional flow cytometry analyses. Sci Rep 2016;6:35928.
17. Connor DE, Exner T, Ma DDF, Joseph JE., The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010;103:1044–1052.
18. Milasan A, Tessandier N, Tan S, Brisson A, Boilard E, Martel C., Extracellular vesicles are present in mouse lymph and their level differs in atherosclerosis. J Extracell Vesicles 2016;5.
19. Cloutier N, Tan S, Boudreau LH, Cramb C, Subbaiah R, Lahey L, Albert A, Shnayder R, Gobezie R, Nigrovic PA, et al. The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components:the microparticle-associated immune complexes. EMBO Mol Med 2013;5:235–249.
20. Rousseau M, Belleannee C, Duchez A-C, Cloutier N, Levesque T, Jacques F, Perron J, Nigrovic PA, Dieude M, Hebert MJ, et al. Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment. PLOS ONE 2015;10:e0116812.
21. Latham SL, Tiberti N, Gokoolparsadh N, Holdaway K, Olivier Couraud P, Grau GER, Combes V., Immuno-analysis of microparticles:probing at the limits of detection. Sci Rep 2015;5:16314.
22. Aatonen M, Grönholm M, Siljander PR-M., Platelet-derived microvesicles:multitalented participants in intercellular communication. Semin Thromb Hemost 2012;38:102–113.
23. Perez-Pujol S, Marker PH, Key NS., Platelet microparticles are heterogeneous and highly dependent on the activation mechanism:Studies using a new digital flow cytometer. Cytometry A 2007;71A:38–45.
24. Flaumenhaft R, Dilks JR, Richardson J, Alden E, Patel-Hett SR, Battinelli E, Klement GL, Sola-Visner M, Italiano JE, Jr. Megakaryocyte-derived microparticles:direct visualization and distinction from platelet-derived microparticles. Blood 2009;113:1112–1121.
25. Gitz E, Pollitt AY, Gitz-Francois JJ, Alshehri O, Mori J, Montague S, Nash GB, Douglas MR, Gardiner EE, Andrews RK, et al. CLEC-2 expression is maintained on activated platelets and on platelet microparticles. Blood 2014;124:2262–2270.
26. Aatonen M, Grönholm M, Siljander PR-M., Platelet-derived microvesicles:multitalented participants in intercellular communication. Semin Thromb Hemost 2012;38:102–113.
27. Duchez A-C, Boudreau LH, Naika GS, Bollinger J, Belleannée C, Cloutier N, Laffont B, Mendoza-Villarroel RE, Lévesque T, Rollet-Labelle E, et al. Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA. Proc Natl Acad Sci USA 2015;112:E3564–E3573.
28. Boudreau LH, Duchez A-C, Cloutier N, Soulet D, Martin N, Bollinger J, Paré A, Rousseau M, Naika GS, Lévesque T, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 2014;124:2173–2183.
29. Laffont B, Corduan A, Plé H, Duchez A-C, Cloutier N, Boilard E, Provost P., Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles. Blood 2013;122:253–261.
30. Ray DM, Spinelli SL, Pollock SJ, Murant TI, O’Brien JJ, Blumberg N, Francis CW, Taubman MB, Phipps RP., Peroxisome proliferator-activated receptor γ and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost 2007.
31. Lindsay CR, Edelstein LC., MicroRNAs in platelet physiology and function. Semin Thromb Hemost 2016;42:215–222.
32. Ueba T, Haze T, Sugiyama M, Higuchi M, Asayama H, Karitani Y, Nishikawa T, Yamashita K, Nagami S, Nakayama T, et al. Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thromb Haemost 2008.
33. Berckmans RJ, Nieuwland R, Böing AN, Romijn FPHTM, Hack CE, Sturk A., Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001;85:639–46.
34. Owens AP, Mackman N., Microparticles in hemostasis and thrombosis. Circ Res 2011;108:1284–1297.
35. Arraud N, Linares R, Tan S, Gounou C, Pasquet J-M, Mornet S, Brisson AR., Extracellular vesicles from blood plasma:determination of their morphology, size, phenotype and concentration. J Thromb Haemost JTH 2014;12:614–627.
36. Arraud N, Gounou C, Turpin D, Brisson AR., Fluorescence triggering:a general strategy for enumerating and phenotyping extracellular vesicles by flow cytometry. Cytom Part J Int Soc Anal Cytol 2016;89:184–195.
37. Rand ML, Wang H, Bang KWA, Packham MA, Freedman J., Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost JTH 2006;4:1621–1623.
38. Rank A, Nieuwland R, Crispin A, Grützner S, Iberer M, Toth B, Pihusch R., Clearance of platelet microparticles in vivo. Platelets 2011;22:111–116.
39. Dasgupta SK, Abdel-Monem H, Niravath P, Le A, Bellera RV, Langlois K, Nagata S, Rumbaut RE, Thiagarajan P., Lactadherin and clearance of platelet-derived microvesicles. Blood 2009;113:1332–1339.
40. Dasgupta SK, Le A, Chavakis T, Rumbaut RE, Thiagarajan P., Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation 2012;125:1664–1672.
41. D’Arcangelo D, Gaetano C, Capogrossi MC., Acidification prevents endothelial cell apoptosis by Axl activation. Circ Res 2002;91:e4–e12.
42. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI., Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007;97:425–434.
43. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FPHTM, Hack CE, Sturk A., Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001;85:810–820.
44. Hoffman M, Monroe DM, Roberts HR., Coagulation factor IXa binding to activated platelets and platelet-derived microparticles:a flow cytometric study. Thromb Haemost 1992;68:74–78.
45. Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ., Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991;266:17261–17268.
46. Zubairova LD, Nabiullina RM, Nagaswami C, Zuev YF, Mustafin IG, Litvinov RI, Weisel JW., Circulating microparticles alter formation, structure, and properties of fibrin clots. Sci Rep 2015;5:17611.
47. Bouchard BA, Mann KG, Butenas S., No evidence for tissue factor on platelets. Blood 2010;116:854–855.
48. Camera M, Brambilla M, Toschi V, Tremoli E., Tissue factor expression on platelets is a dynamic event. Blood 2010;116:5076–5077.
49. Østerud B, Olsen JO., Human platelets do not express tissue factor. Thromb Res 2013;132:112–115.
50. Lopez-Vilchez I, Diaz-Ricart M, Galan AM, Roque M, Caballo C, Molina P, White JG, Escolar G., Internalization of tissue factor-rich microvesicles by platelets occurs independently of GPIIb-IIIa, and involves CD36 receptor, serotonin transporter and cytoskeletal assembly. J Cell Biochem 2016;117:448–457.
51. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991;77:2641–2648.
52. Castaman G, Yu-Feng L, Rodeghiero F., A bleeding disorder characterised by isolated deficiency of platelet microvesicle generation. Lancet Lond Engl 1996;347:700–701.
53. Castaman G, Yu-Feng L, Battistin E, Rodeghiero F., Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol 1997;96:458–463.
54. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM., Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996;87:1409–1415.
55. Weiss HJ, Vicic WJ, Lages BA, Rogers J., Isolated deficiency of platelet procoagulant activity. Am J Med 1979;67:206–213.
56. Satta N, Toti F, Fressinaud E, Meyer D, Freyssinet JM., Scott syndrome:an inherited defect of the procoagulant activity of platelets. Platelets 1997;8:117–124.
57. Zwaal RFA, Comfurius P, Bevers EM., Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta BBA-Mol Cell Biol Lipids 2004;1636:119–128.
58. Castoldi E, Collins PW, Williamson PL, Bevers EM., Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome. Blood 2011;117:4399–4400.
59. Burnouf T, Goubran HA, Chou M-L, Devos D, Radosevic M., Platelet microparticles:Detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev 2014;28:155–166.
60. Jy W, Horstman LL, Arce M, Ahn YS., Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992;119:334–345.
61. Álvarez-Román MT, Fernández-Bello I, Jiménez-Yuste V, Martín-Salces M, Arias-Salgado EG, Rivas Pollmar MI, Justo Sanz R, Butta NV., Procoagulant profile in patients with immune thrombocytopenia. Br J Haematol 2016.
62. Brodsky RA., Paroxysmal nocturnal hemoglobinuria. Blood 2014;124:2804–2811.
63. Hugel B, Socié G, Vu T, Toti F, Gluckman E, Freyssinet JM, Scrobohaci ML., Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999;93:3451–3456.
64. Wiedmer T, Hall SE, Ortel TL, Kane WH, Rosse WF, Sims PJ., Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 1993;82:1192–1196.
65. Heddle NM, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG., A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion (Paris) 1993;33:794–797.
66. Sugawara A, Nollet KE, Yajima K, Saito S, Ohto H., Preventing platelet-derived microparticle formation—and possible side effects—with prestorage leukofiltration of whole blood. Arch Pathol Lab Med 2010;134:771–775.
67. Nomura S, Okamae F, Abe M, Hosokawa M, Yamaoka M, Ohtani T, Onishi S, Matsuzaki T, Teraoka A, Ishida T, et al. Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated leukocytes. Clin Appl Thromb 2000;6:213–221.
68. Blumberg N, Gettings KF, Turner C, Heal JM, Phipps RP., An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion (Paris) 2006;46:1813–1821.
69. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC., Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006;108:2455–2462.
70. West AP, Shadel GS, Ghosh S., Mitochondria in innate immune responses. Nat Rev Immunol 2011;11:389–402.
71. Lee Y-L, King MB, Gonzalez RP, Brevard SB, Frotan MA, Gillespie MN, Simmons JD. Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns:a potential effector of transfusion-related acute lung injury. J Surg Res 2014;191:286–289.
72. Marcoux G, Duchez A-C, Rousseau M, Lévesque T, Boudreau LH, Thibault L, Boilard E., Microparticle and mitochondrial release during extended storage of different types of platelet concentrates. Platelets 2016;0:1–9.
73. Yasui K, Matsuyama N, Kuroishi A, Tani Y, Furuta RA, Hirayama F., Mitochondrial damage-associated molecular patterns as potential proinflammatory mediators in post–platelet transfusion adverse effects. Transfusion (Paris) 2016;56:1201–1212.
74. Knijff-Dutmer, EaJ, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MaFJ. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002;46:1498–1503.
75. György B, Szabó TG, Turiák L, Wright M, Herczeg P, Lédeczi Z, Kittel A, Polgár A, Tóth K, Dérfalvi B, et al. Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases. PLOS ONE 2012;7:e49726.
76. Boilard E, Nigrovic PA, Larabee K, Watts GFM, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O’Donnell E, Farndale RW, Ware J, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010;327:580–583.
77. Pereira J, Alfaro G, Goycoolea M, Quiroga T, Ocqueteau M, Massardo L, Pérez C, Sáez C, Panes O, Matus V, et al. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost 2006;95:94–99.
78. Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg J-E, Toti F, Benessiano J, Gay S, Freyssinet JM, et al. Increased levels of circulating microparticles in primary Sjögren’s syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 2009;11:R156.
79. Nielsen CT, Østergaard O, Johnsen C, Jacobsen S, Heegaard NHH., Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum 2011;63:3067–3077.
80. Fortin PR, Cloutier N, Bissonnette V, Aghdassi E, Eder L, Simonyan D, Laflamme N, Boilard E., Distinct subtypes of microparticle-containing immune complexes are associated with disease activity, damage, and carotid intima-media thickness in systemic lupus erythematosus. J Rheumatol 2016.
81. Michelsen AE, Notø, A-T, Brodin E, Mathiesen EB, Brosstad F, Hansen J-B., Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state. Thromb Res 2009;123:881–886.
82. Kuriyama N, Nagakane Y, Hosomi A, Ohara T, Kasai T, Harada S, Takeda K, Yamada K, Ozasa K, Tokuda T, et al. Evaluation of factors associated with elevated levels of platelet-derived microparticles in the acute phase of cerebral infarction. Clin Appl Thromb Off J Int Acad Clin Appl Thromb 2010;16:26–32.
83. Hartopo AB, Puspitawati I, Gharini PPR, Setianto BY., Platelet microparticle number is associated with the extent of myocardial damage in acute myocardial infarction. Arch Med Sci AMS 2016;12:529–537.
84. Rajavashisth T, Qiao JH, Tripathi S, Tripathi J, Mishra N, Hua M, Wang XP, Loussararian A, Clinton S, Libby P, et al. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. J Clin Invest 1998;101:2702–2710.
85. Barry OP, Praticò D, Savani RC, FitzGerald GA., Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998;102:136–144.
86. Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C., Platelet microparticles:a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005;25:1512–1518.
87. Laffont B, Corduan A, Rousseau M, Duchez A-C, Lee CHC, Boilard E, Provost P., Platelet microparticles reprogram macrophage gene expression and function. Thromb Haemost 2016;115:311–323.
88. Gidlöf O, van der Brug M, Ohman J, Gilje P, Olde B, Wahlestedt C, Erlinge D., Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood 2013;121:3908–3917, S1-26.
89. Kim HK, Song KS, Chung J-H, Lee KR, Lee S-N., Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004;124:376–384.
90. Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D., Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 2005;67:30–38.
91. Toth B, Liebhardt S, Steinig K, Ditsch N, Rank A, Bauerfeind I, Spannagl M, Friese K, Reininger AJ., Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 2008.
92. Ren JG, Man QW, Zhang W, Li C, Xiong XP, Zhu JY, Wang WM, Sun ZJ, Jia J, Zhang WF, et al. Elevated level of circulating platelet-derived microparticles in oral cancer. J Dent Res 2016;l95:87–93.
93. Dymicka-Piekarska V, Gryko M, Lipska A, Korniluk A, Siergiejko E, Kemona H., Platelet-derived microparticles in patients with colorectal cancer. J Cancer Ther 2012;3:898–901.
94. Kapur R, Zufferey A, Boilard E, Semple JW., Nouvelle cuisine:platelets served with inflammation. J Immunol 2015;194:5579–5587.
95. Forlow SB, McEver RP, Nollert MU., Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000;95:1317–1323.
96. Dinkla S, van Cranenbroek B, van der Heijden WA, He X, Wallbrecher R, Dumitriu IE, van der Ven AJ, Bosman GJ, Koenen HJ, Joosten I., Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin. Blood 2016;127:1976–1986.
97. Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL., Platelet-mediated modulation of adaptive immunity:unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 2008;111:5028–5036.
98. Corrales-Medina VF, Simkins J, Chirinos JA, Serpa JA, Horstman LL, Jy W, Ahn YS., Increased levels of platelet microparticles in HIV-infected patients with good response to highly active antiretroviral therapy. JAIDS J Acquir Immune Defic Syndr 2010;54:217–218.
99. Rozmyslowicz T, Majka M, Kijowski J, Murphy SL, Conover DO, Poncz M, Ratajczak J, Gaulton GN, Ratajczak MZ., Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS Lond Engl 2003;17:33–42.
100. Boilard E, Paré G, Rousseau M, Cloutier N, Dubuc I, Lévesque T, Borgeat P, Flamand L., Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation. Blood 2014;123:2854–2863.
101. Punyadee N, Mairiang D, Thiemmeca S, Komoltri C, Pan-ngum W, Chomanee N, Charngkaew K, Tangthawornchaikul N, Limpitikul W, Vasanawathana S, et al. Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection. J Virol 2015;89:1587–1607.
102. Haldar K, Murphy SC, Dan J, Milner A, Taylor TE., Malaria:mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol Mech Dis 2007;2:217–249.
103. Campos FM, Franklin BS, Teixeira-Carvalho A, Filho AL, de Paula SC, Fontes CJ, Brito CF, Carvalho LH., Augmented plasma microparticles during acute Plasmodium vivax infection. Malar J 2010;9:327.
104. Faille D, Combes V, Mitchell AJ, Fontaine A, Juhan-Vague I, Alessi M-C, Chimini G, Fusaï T, Grau GE., Platelet microparticles:a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J 2009;23:3449–3458.